InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Medicus Pharma Ltd.

MDCX Clue Score17
United States Fiscal year ends December CIK 0001997296
$0.09 -9.62% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.09 −96.52% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2023Operating income−4.7Net income−5.3EPS, diluted−1.53Fiscal year 2024Operating income−11.2Net income−11.2EPS, diluted−1.16Fiscal year 2025Operating income−34.4Net income−47.3EPS, diluted−2.74
FY2023FY2024FY2025
Operating income −4.7 −11.2 −34.4
Net income −5.3 −11.2 −47.3
Growth
EPS, diluted −1.53 −1.16 −2.74

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−4.2Fiscal year 2024Operating cash flow−10.2Fiscal year 2025Operating cash flow−22.8
FY2023FY2024FY2025
Operating cash flow −4.2 −10.2 −22.8

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash1.7Shareholders’ equity1.1Fiscal year 2024Cash4.2Shareholders’ equity3.1Fiscal year 2025Cash8.7Shareholders’ equity−0.1
FY2023FY2024FY2025
Cash 1.7 4.2 8.7
Shareholders’ equity 1.1 3.1 −0.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
−478.2% −355.9% n/a
−280.8% −197.6% −469.9%
Balance and payout
41.3% 44.5% 99.6%